Insider Buying: AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Acquires $212,480.00 in Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett acquired 83,000 shares of the company’s stock in a transaction dated Tuesday, March 17th. The stock was acquired at an average price of $2.56 per share, with a total value of $212,480.00. Following the purchase, the insider owned 6,676,059 shares in the company, valued at approximately $17,090,711.04. This represents a 1.26% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Thursday, March 19th, Jorey Chernett bought 77,702 shares of AirSculpt Technologies stock. The stock was acquired at an average cost of $2.64 per share, for a total transaction of $205,133.28.
• On Monday, March 16th, Jorey Chernett bought 105,848 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.43 per share, with a total value of $257,210.64.
• On Wednesday, March 11th, Jorey Chernett purchased 88,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.15 per share, for a total transaction of $189,200.00.
• On Friday, March 6th, Jorey Chernett acquired 45,600 shares of AirSculpt Technologies stock. The shares were bought at an average price of $2.00 per share, with a total value of $91,200.00.
• On Wednesday, March 4th, Jorey Chernett acquired 30,000 shares of AirSculpt Technologies stock. The shares were bought at an average cost of $1.87 per share, with a total value of $56,100.00.
• On Tuesday, March 3rd, Jorey Chernett bought 80,000 shares of AirSculpt Technologies stock. The stock was purchased at an average price of $1.71 per share, for a total transaction of $136,800.00.

AirSculpt Technologies Trading Down 2.6%

Shares of AirSculpt Technologies stock opened at $2.65 on Friday. AirSculpt Technologies, Inc. has a 12-month low of $1.51 and a 12-month high of $12.00. The stock has a market capitalization of $165.47 million, a P/E ratio of -8.83 and a beta of 2.75. The company has a 50-day simple moving average of $2.27 and a 200 day simple moving average of $4.58. The company has a quick ratio of 0.51, a current ratio of 0.51 and a debt-to-equity ratio of 0.63.

Institutional Trading of AirSculpt Technologies

Large investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd bought a new stake in shares of AirSculpt Technologies in the 4th quarter valued at about $155,000. Aristides Capital LLC acquired a new stake in shares of AirSculpt Technologies in the fourth quarter valued at approximately $140,000. Virtu Financial LLC bought a new position in shares of AirSculpt Technologies during the 4th quarter worth approximately $30,000. XTX Topco Ltd increased its holdings in shares of AirSculpt Technologies by 265.2% during the 4th quarter. XTX Topco Ltd now owns 179,813 shares of the company’s stock worth $356,000 after acquiring an additional 130,581 shares during the last quarter. Finally, Tudor Investment Corp ET AL acquired a new position in shares of AirSculpt Technologies during the 4th quarter worth approximately $219,000. Institutional investors and hedge funds own 91.54% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of AirSculpt Technologies in a research report on Monday, December 29th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average target price of $6.00.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.